Copyright Reports & Markets. All rights reserved.

Global Neuromodulation Devices and Implantable Infusion Pumps Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type
    • 1.4.2 Spinal Cord Stimulation
    • 1.4.3 Deep Brain Stimulation
    • 1.2.4 Sacral Nerve Stimulation
    • 1.2.5 Vagal Nerve Stimulation
    • 1.2.6 Gastric Stimulation
    • 1.2.7 Transcranial Magnetic Stimulation
    • 1.2.8 Transcutaneous Electrical Stimulation
    • 1.2.9 Other
  • 1.3 Market by Application
    • 1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application
    • 1.3.2 Parkinson's Disease
    • 1.3.3 Epilepsy
    • 1.3.4 Pain
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales
    • 2.4.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2016-2021)
    • 2.4.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2022-2027)
  • 2.5 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue
    • 2.5.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
    • 3.1.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Sales in 2020
  • 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers
    • 3.2.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2020
  • 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
    • 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Type (2016-2021)
    • 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2027)
  • 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
    • 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2027)
  • 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type
    • 4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
    • 4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
    • 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Application (2016-2021)
    • 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2027)
  • 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
    • 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2027)
  • 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application
    • 5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
    • 5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
    • 6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
    • 6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
  • 6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
    • 6.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
    • 6.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
  • 6.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
    • 6.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
    • 6.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
    • 7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2027)
    • 7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2017-2027)
  • 7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
    • 7.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2027)
    • 7.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2017-2027)
  • 7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
    • 7.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2027)
    • 7.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
    • 8.1.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
    • 8.2.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
    • 8.3.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
    • 9.1.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2027)
    • 9.1.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2027)
  • 9.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
    • 9.2.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2027)
    • 9.2.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2027)
  • 9.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
    • 9.3.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2027)
    • 9.3.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
    • 6.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
    • 6.2.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
    • 6.3.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Overview
    • 11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.1.5 Medtronic Related Developments
  • 11.2 Boston Scientific Corporation
    • 11.2.1 Boston Scientific Corporation Corporation Information
    • 11.2.2 Boston Scientific Corporation Overview
    • 11.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.2.5 Boston Scientific Corporation Related Developments
  • 11.3 Abbott
    • 11.3.1 Abbott Corporation Information
    • 11.3.2 Abbott Overview
    • 11.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.3.5 Abbott Related Developments
  • 11.4 Synapse Biomedical
    • 11.4.1 Synapse Biomedical Corporation Information
    • 11.4.2 Synapse Biomedical Overview
    • 11.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.4.5 Synapse Biomedical Related Developments
  • 11.5 Nevro Corporation
    • 11.5.1 Nevro Corporation Corporation Information
    • 11.5.2 Nevro Corporation Overview
    • 11.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.5.5 Nevro Corporation Related Developments
  • 11.6 Neuropace
    • 11.6.1 Neuropace Corporation Information
    • 11.6.2 Neuropace Overview
    • 11.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.6.5 Neuropace Related Developments
  • 11.7 Cyberonics
    • 11.7.1 Cyberonics Corporation Information
    • 11.7.2 Cyberonics Overview
    • 11.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.7.5 Cyberonics Related Developments
  • 11.8 Autonomic Technologies
    • 11.8.1 Autonomic Technologies Corporation Information
    • 11.8.2 Autonomic Technologies Overview
    • 11.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.8.5 Autonomic Technologies Related Developments
  • 11.9 Avery Biomedical
    • 11.9.1 Avery Biomedical Corporation Information
    • 11.9.2 Avery Biomedical Overview
    • 11.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.9.5 Avery Biomedical Related Developments
  • 11.10 Greatbatch Medical
    • 11.10.1 Greatbatch Medical Corporation Information
    • 11.10.2 Greatbatch Medical Overview
    • 11.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.10.5 Greatbatch Medical Related Developments
  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Overview
    • 11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
    • 11.1.5 Medtronic Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
  • 12.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
  • 12.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing
    • 12.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels
    • 12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
  • 12.5 Neuromodulation Devices and Implantable Infusion Pumps Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
  • 13.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
  • 13.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
  • 13.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

14 Key Findings in The Global Neuromodulation Devices and Implantable Infusion Pumps Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Neuromodulation Devices and Implantable Infusion Pumps market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulation Devices and Implantable Infusion Pumps market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Spinal Cord Stimulation
    Deep Brain Stimulation
    Sacral Nerve Stimulation
    Vagal Nerve Stimulation
    Gastric Stimulation
    Transcranial Magnetic Stimulation
    Transcutaneous Electrical Stimulation
    Other

    Segment by Application
    Parkinson's Disease
    Epilepsy
    Pain
    Other

    By Company
    Medtronic
    Boston Scientific Corporation
    Abbott
    Synapse Biomedical
    Nevro Corporation
    Neuropace
    Cyberonics
    Autonomic Technologies
    Avery Biomedical
    Greatbatch Medical

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now